Recommendations on the Development of a Bioanalytical Assay for 4β-Hydroxycholesterol, an Emerging Endogenous Biomarker of CYP3A Activity.
about
Perspective: 4β-hydroxycholesterol as an emerging endogenous biomarker of hepatic CYP3A.4β-Hydroxycholesterol level significantly correlates with steady-state serum concentration of the CYP3A4 substrate quetiapine in psychiatric patients.Differences in the Serum 4β-hydroxycholesterol Levels of Patients with Chronic HCV Infection: A Possible Impact on the Efficacy and Safety of IFN-free Treatment.Feedback from the EBF - Focus Workshop: bringing assay validation and analysis of biomarkers into practice.Elevated 4β-hydroxycholesterol/cholesterol ratio in anorexia nervosa patients
P2860
Recommendations on the Development of a Bioanalytical Assay for 4β-Hydroxycholesterol, an Emerging Endogenous Biomarker of CYP3A Activity.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Recommendations on the Develop ...... s Biomarker of CYP3A Activity.
@en
type
label
Recommendations on the Develop ...... s Biomarker of CYP3A Activity.
@en
prefLabel
Recommendations on the Develop ...... s Biomarker of CYP3A Activity.
@en
P2093
P1433
P1476
Recommendations on the Develop ...... s Biomarker of CYP3A Activity.
@en
P2093
André Iffland
Angela Goodenough
Anne-Françoise Aubry
Brian Dean
James McLeod
Naidong Weng
Ulf Diczfalusy
Ziping Yang
P2888
P304
P356
10.1208/S12248-016-9949-3
P407
P577
2016-06-27T00:00:00Z
P6179
1035920517